FDA Inspection 828408 — OriGen Biomedical, Inc.

OriGen Biomedical, Inc. — FEI 1000160256

The FDA completed an inspection of OriGen Biomedical, Inc. on Apr 26, 2013 in Austin, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 5 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 26, 2013
Fiscal Year
2013
Product Type
Devices
Project Area
Compliance: Devices
Location
Austin, TX (United States)

Citations

IDCFRDescription
232821 CFR 820.22Quality audits - auditor independence
310321 CFR 820.30(i)Design changes - Lack of or Inadequate Procedures
367821 CFR 820.30(g)Design Validation - Risk analysis not performed/inadequate
369621 CFR 820.100(b)Documentation
54621 CFR 820.75(a)Lack of or inadequate process validation

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.